The StraightFrom Leukopak REAlease Anti-TCRγ/δ MicroBead Kit, human was developed for rapid positive selection of TCRγ/δ+ T cells directly from Leukopak using the MultiMACS™ Cell24 Separator Plus for semi-automated separation. No sample preparation is required, including density gradient centrifugation or erythrocyte lysis. The purified target cells are bead-free, practical for consecutive magnetic isolations, and can be label-free so that epitopes are available for any downstream application.
Related products for StraightFrom® Leukopak® REAlease® Anti-TCRγ/δ MicroBead Kit, human
The StraightFrom Leukopak REAlease Anti-TCRγ/δ MicroBead Kit, human was developed for rapid positive selection of TCRγ/δ+ T cells directly from Leukopak using the MultiMACS™ Cell24 Separator Plus for semi-automated separation. No sample preparation is required, including density gradient centrifugation or erythrocyte lysis. The purified target cells are bead-free, practical for consecutive magnetic isolations, and can be label-free so that epitopes are available for any downstream application.
TCRγ/δ+ T cells are labeled with StraightFrom Leukopak REAlease Anti-TCRγ/δ-Biotin, human (REAlease Biotin Complex). Subsequently, StraightFrom Leukopak REAlease Anti-Biotin MicroBeads (Anti-TCRγ/δ, human) bind to the REAlease Biotin Complex. Then, the cell suspension is loaded onto a Multi-24 Whole Blood Column Block, which is placed in the magnetic field of a MultiMACS Cell24 Separator Plus. The magnetically labeled cells are retained within the column. The unlabeled non-target cells flow through; this cell fraction is thus depleted of TCRγ/δ+ T cells. Using the REAlease Bead Release Reagent, which removes the MicroBeads from the cell, target cells are eluted within the magnetic field. Finally, during the subsequent incubation with the REAlease Release Reagent, the REAlease Biotin Complex monomerizes and dissociates from the cell surface leaving the cells free of all labels.
Isolation of TCRγ/δ+ T cells from Leukopak. The purified TCRγ/δ+ T cells are well suited for further flow cytometric, functional or molecular analysis.
Whole Blood columns, Multi-24 Whole Blood Column Block
TCRγ/δ+ T cells were isolated from ½ Leukopak using the StraightFrom Leukopak REAlease Anti-TCRγ/δ MicroBead Kit, human, the Multi-24 Whole Blood Column Block, and a MultiMACS Cell24 Separator Plus. Cells were fluorescently stained with TCRγ/δ Antibody-FITC, CD3-APC, and Biotin AntibodyAPC and analyzed by flow cytometry using the MACSQuant X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. The TCRγ/δ+ cell content of the isolated fraction is typically 97 ± 2% (mean ± SD) for Leukopak.
The efficient removal of all labels was shown by using Biotin Antibody-APC to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (MicroBead-free TCRγ/δ+ T cells), whereas the label-free TCRγ/δ+ T cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation.